Scimitar syndrome
MONDO:0015987Scimitar syndrome is characterized by a combination of cardiopulmonary anomalies including partial anomalous pulmonary venous return connection of the right lung to the inferior caval vein leading to the creation of a left-to-right shunt.
Also known as: Epibronchial right pulmonary vein syndrome, Halasz syndrome, congenital pulmonary venolobar syndrome, hypogenetic lung syndrome
67 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New heart ablation technique could tame dangerous rhythms in adults born with heart defects
Disease control TerminatedThis trial investigates whether pulsed field ablation (PFA) can safely isolate the pulmonary veins in adults with congenital heart disease who experience atrial tachycardia. Participants will undergo PFA during a standard ablation procedure. The study measures how well the veins …
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could a gentler ICU environment boost brain development in heart babies?
Disease control OngoingThis study tests a behavioral program called Individualized Developmental Care (NIDCAP) for newborns with complex congenital heart disease. The program aims to reduce stress from the hospital environment by supporting parent involvement, creating a soothing setting, and adjusting…
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New heart valve study aims to improve lives of heart defect patients
Disease control OngoingThis study looks at how well the Harmony Transcatheter Pulmonary Valve (TPV) works when used by doctors in everyday practice. It involves 174 people with congenital heart disease who need a new pulmonary valve. The main goal is to see if the valve works properly without needing a…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Stem cells given during infant heart surgery: a safety first
Disease control OngoingThis early-phase trial tests whether giving stem cells (from a donor) during heart-lung bypass surgery is safe for infants under 6 months with certain congenital heart defects. Seventeen infants will receive the cells while undergoing heart repair. The main goal is to check for s…
Phase: PHASE1 • Sponsor: Catherine Bollard • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a common heart drug fix a rare surgery complication in kids?
Disease control TerminatedThis study tests whether propranolol, a drug often used for high blood pressure, can safely treat chylothorax—a buildup of lymphatic fluid—in children after open heart surgery. About 50 children aged 7 days to 18 years with congenital heart disease will receive either propranolol…
Phase: PHASE1, PHASE2 • Sponsor: June Wu • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New oxygen strategy could save young hearts after surgery
Disease control ENROLLING_BY_INVITATIONThis study tests a new way to manage blood flow and oxygen in children right after heart surgery. The goal is to help their bodies use oxygen better during the critical first 8 hours, which may prevent dangerous drops in blood pressure or heart function. About 300 children weighi…
Phase: NA • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New heart solution tested in Kids' surgery: could it offer better protection?
Disease control TerminatedThis study compares two solutions, Custodiol and Custodiol-N, used to protect the heart during surgery for children with congenital heart defects. About 100 children will receive one of the two solutions while on a heart-lung machine. The goal is to see which one is safer and bet…
Phase: PHASE2 • Sponsor: Dr. F. Köhler Chemie GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New No-Scalpel heart valve offers hope for leaky hearts
Disease control OngoingThis study is testing a new type of heart valve called the Harmony TPV, which is placed using a thin tube (catheter) instead of open-heart surgery. It is for people with congenital heart disease who have a leaky pulmonary valve. The study will check if the valve works well and is…
Phase: NA • Sponsor: Medtronic Heart Valves • Aim: Disease control
Last updated Jun 26, 2026 18:49 UTC
-
Which nerve block eases Children's heart surgery pain better?
Symptom relief ENROLLING_BY_INVITATIONThis trial compares two ultrasound-guided nerve blocks—erector spinae plane block and modified pectoral fascial plane block—for pain control in children undergoing congenital heart surgery. Forty children will be randomly assigned to receive one of the blocks before their incisio…
Phase: NA • Sponsor: Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Blood protein test could predict Post-Surgery risks in kids with heart defects
Knowledge-focused ENROLLING_BY_INVITATIONThis study at Boston Children's Hospital will test whether measuring thousands of proteins in a few drops of blood can predict which children with congenital heart disease will have serious complications after heart surgery. Researchers will collect blood samples from 60 children…
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Massive gene hunt aims to unlock secrets of heart birth defects
Knowledge-focused OngoingThis study is collecting DNA and health information from 32,000 people with congenital heart defects. Researchers hope to find genetic causes and understand why outcomes vary. No treatment is being tested—this is a research study to gather knowledge.
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC